DNA Methylation Market is expected to reach US$ 5815.49 Million by 2033 | FMI

 The global DNA Methylation Market is expected to generate a market value of US$ 1437.5 Million in 2023 and a market value of US$ 5815.49 Million by 2033, with a CAGR of 15% from 2023 to 2033. The increasing number of cancer cases worldwide remains the primary driver of the DNA methylation market's expected growth. In the historical period 2016 to 2021, the market for DNA methylation grew at a CAGR of 11%.

To learn more about this report @ https://www.futuremarketinsights.com/reports/dna-methylation-market

The significant increase in the adoption of epigenetics-based treatment strategies, coupled with the broad nucleic acid-based diagnostic tests & kits commercialization is projected to drive the growth of the market. In May 2022, an article published in PubMed stated that the epigenetics-based treatment strategies are to be used for studying Alzheimer’s disease.

Moreover, Key players operating in the market are taking several initiatives such as new product developments, entering into a strategic alliance, and regional expansion among others. All these factors are positively influencing the demand for DNA methylation market.


Key Takeaways from the Market Study

  • By technology, sequencing is expected to possess 35% market share for DNA methylation market in 2023.
  • By product, consumables are expected to possess 35% market share for DNA methylation market in 2023.
  • By application, clinical research is expected to possess 40% market share for DNA methylation market in 2023.
  • By application, diagnostic segment is anticipated to witness the fastest growth in the coming years with a CAGR of 16%.
  • By end use, pharmaceutical and biotechnology end-use segment are expected to possess 42% market share for DNA methylation in 2023.
  • North America is expected to possess 40% market share for DNA methylation market in 2023.
  • Asia Pacific is expected to possess 38% market share for DNA methylation market in 2023.

“Expenditure on research and development along with government funding is expected to accelerate the growth of DNA methylation market.” comments a Future Market Insights analyst.

Competitive Landscape

Some prominent players in the global DNA methylation market include New England Biolabs, Sysmex Corporation, Abcam plc., F. Hoffmann-La Roche Ltd., Diagenode Diagnostics S.A., Thermo-Fisher Scientific Inc., Agilent Technologies Inc., BioRad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Active Motif, Inc., Illumina Inc.,EpiGentek Group Inc., Pacific Biosciences Inc., New England Biolabs Inc., Merck KGaA, Zymo Research Corporation, PerkinElmer Inc.

  • In May 2022, Oxford Nanopore announced integrating Remora, a technique that offers accurate and real-time epigenetic insights with nanopore sequencing software. This would further offer simple access to accurate whole genome methylation detection.
  • In June 2020, Base Genomics announced of advancing and developing its DNA methylation technology. the aim is to sequence a large amount of epigenetic data from a blood test which could revolutionize the preventative medicine arena.

Key Segments Profiled in the DNA Methylation Industry Survey

Technology:

  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Sequencing
  • Others

Product:

  • Consumables
  • Kits & Reagents
  • Enzymes
  • Instruments & Software

Application:

  • Gene Therapy
  • Clinical Research
  • Diagnostics
  • Others

End-use:

  • Hospital & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academia

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more